1-(4,6-Dimethoxypyrimidin-2-yl)-3-(3-(trifluoromethyl)phenyl)urea

Catalog No. :
ACMFHH744
CAS No. :
190954-81-5
Molecular Formula :
C14H13F3N4O3
Molecular Weight :
342.28

IUPAC Name:1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-(trifluoromethyl)phenyl)urea

1-(4,6-Dimethoxypyrimidin-2-yl)-3-(3-(trifluoromethyl)phenyl)urea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4,6-Dimethoxypyrimidin-2-yl)-3-(3-(trifluoromethyl)phenyl)urea
IUPAC Name1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-(trifluoromethyl)phenyl)urea
MDL No.MFCD02674794
Molecular FormulaC14H13F3N4O3
Molecular Weight342.28
SMILESO=C(NC1=CC=CC(C(F)(F)F)=C1)NC2=NC(OC)=CC(OC)=N2
InChI KeyOMGRQDVVMYEKLC-UHFFFAOYSA-N
Synonym3-(4,6-dimethoxypyrimidin-2-yl)-1-[3-(trifluoromethyl)phenyl]urea;N-(4,6-DIMETHOXY-2-PYRIMIDINYL)-N'-(3-(TRIFLUOROMETHYL)PHENYL)UREA;N-(4,6-DIMETHOXY-2-PYRIMIDINYL)-N'-(3-(TRIFLUOROMETHYL)PHENYL)UREA
CAS No.190954-81-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMFHH744 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWZFI502 route compound structure diagram
    ACWZFI50236315-01-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMFHH744 route product structure diagram
    ACMFHH744190954-81-5
Inquiry

2. ACMFHH744 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRAUC529 route compound structure diagram
    ACRAUC5292646-97-1 In Stock
  4. Then
  5. ACMFHH744 route product structure diagram
    ACMFHH744190954-81-5
Inquiry

Comments (0)